Global Healthcare Specialty Enzymes Market by Source (Carbohydrases, Proteases) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global healthcare specialty enzymes market was valued at USD 2.5 billion in 2019. It is projected to grow at 6.2% compound annual growth rate (CAGR), between 2020 and 2027. In recent years, the rising incidence of metabolic diseases has led to an increase in the use of enzymes in clinical examinations. It is possible to identify the source of disease by examining enzymes specific to particular tissues and organs. The preferred method for diagnosing cardiovascular disease is to monitor the blood levels of Lactate Dehydrogenase, which is found in the heart and in skeletal muscle.

Over the years, enzyme-based biosensors gained significant popularity among healthcare professionals. This is expected to lead to increased market penetration in diagnostic and research applications. Amperometry-based enzymes biosensors are on the rise. This is due to their multidisciplinary approach that includes materials science, electrochemistry and biological chemistry. Increasing research efforts are directed towards the exploration of the potential and accuracy such HTML3_ biosensors HTML3_ for diagnostic as well as research purposes.

The demand for healthcare specialty enzymes has been significant in clinical applications and diagnosis. Among others, ss-galactosidase and peroxidase are frequently included in Enzyme-Linked Immunosorbent Assays (ELISA). The demand for ELISA for diagnosis of infectious diseases is expected to increase the market for specialty enzymes in healthcare. They are being used in the detection and analysis of hormones, drugs, serum constituents, and oncofetal protein.

ELISA can also be used to analyze causative agents, such as bacteria, viruses and mycotic organisms. The enzyme multiplied immuneassay technique (EMIT) is a popular tool for analyzing Lysozyme, Malate dehydrogenase and other causative agents. EMIT can also detect urea, glucose and cholesterol in blood.

Product Insights

Carbohydrases accounted for approximately 30% of the total revenue in 2019, as they are used on a large scale in the diagnostics and biotechnology industries. Many companies offer amylase that can be used to solve lab-based problems. Amano Enzyme Inc., American Laboratories, Inc., Analyticon Biotechnologies AG, Angstrom Biotech Pvt. Ltd., and Lab Care Diagnostics India Pvt. Ltd. provides amylase for the diagnosis and treatment of pancreatic diseases or laboratory-scale research protocols.

Recent years have seen the transition from laboratory-based diagnostic protocols to molecular diagnosis. This can be attributed to the lack of labor-intensive microbiology diagnostic tests in diagnostic centers and laboratories.

Because they provide faster results, molecular diagnostics tests can be a powerful alternative to conventional diagnostic modalities. This will contribute to the revenue from this segment of the market for healthcare specialty enzymes, as both nucleases and polymerases play an important role in molecular diagnosis.

Source Insights

In 2019, the microbial enzymes market accounted for 46.1% of all the revenue sources for healthcare specialty enzymes. This is due to the unique properties of enzymes derived from microbes. Fermented microbial enzymes offer many advantages, including wide ranges in pH, temperatures, as well as varying specificities about the substrate. As the current demand for proteases is not met by both animal- and plant-derived proteases, microbes have been used more frequently in the production of these enzymes. Microorganisms are a powerful alternative to large-scale production of proteases.

Enzyme engineering is a method of creating a wide range of products with useful diagnostic implications. The source selection and organism play a crucial role in the maintenance of enzyme functionality. Source selection is based on organisms' ability to produce the desired yield in shorter periods of time with minimal secondary metabolites.

Technique Insights

Due to their higher use in clinical analysis, the clinical chemistry segment was the dominant market for healthcare specialty enzymes. It accounted for more than 28.0% revenue share in 2019. The majority of enzymes are used in clinical chemistry. However, the substantial potential of nucleases and polymerases in diagnosis has greatly contributed to the high revenue generated by molecular diagnosing in the market for specialty enzymes for healthcare.

The market for specialty enzymes for healthcare will see the most rapid growth in the next few years in immunodiagnostic and immunoassays. Many market players are interested in integrating enzyme-based products into diagnostic immunodiagnostic methods. For example, Thermo Fischer Scientific Inc. has enzyme-based products that can also be used for immunodiagnostic purposes.

Specialty enzymes for healthcare have been a key component of routine laboratory procedures and are now a vital part of molecular cloning methods. Many manufacturers have developed products that can modify and create nucleic acid from different sources. It is therefore important to choose the right enzyme for a given task. Polymerases are the most commonly used enzymes in molecular cloning research.

Useage Insights

The largest revenue share was 64.7% for healthcare specialty enzymes in 2019, which have tremendous applications in both the clinical and research space. This sector will also see rapid growth, thanks to robust funding from both corporate and national companies. The recent shift to products derived from biological compounds has been observed by drug manufacturers in the U.S.

This industry will see rapid growth in the next few years. The specialty sector is expected to show the most growth, compared to the industrial sector which is growing moderately. These enzymes can be classified as low-volume with high value-added uses. A number of factors, including declining DNA sequencing costs, increased awareness about new healthcare specialty enzyme products and the demographic transition, have pushed the use of healthcare specialty enzymes in research and diagnostic activities.

Application Insights

The market for healthcare specialty enzymes was dominated by infectious diseases, with a 28.0% revenue share in 2019. This segment is expected to be the most dominant due to the use of enzyme biomarker testing. The current COVID-19 pandemic across the globe will further propel this segment to an exponential growth rate from 2020 to 2027. Richcore Lifesciences, an Indian biotechnology company, is planning to introduce 2pivotalenzyme component components. These components will be used largely in the COVID-19 diagnostic kits based upon Reverse Transcription polymerase Chain Reactions (RT-PCR).

Creative Enzymes, a U.S.-based manufacturer, has increased its portfolio of healthcare specialty enzymes. This acknowledges the current use of Nucleic Acid Testing (NAT) as well as serological tests for COVID-19 diagnostic. Oncology-based applications will see the greatest growth due to the increasing use of R&D in the disease etiology research.

End-use Insights

In 2019, the highest revenue share in the market for specialty enzymes in healthcare was held by Laboratories at 44.8%. Because of the large use of enzyme products in research operations, this is a significant advantage. For chronic diseases such as myocardial injury, infectious diseases, and inflammatory disorders, laboratories are eager to adopt healthcare specialty enzyme products. The research aimed at exploring the potential of healthcare specialty products in designing effective therapies are also increasing.

Hospitals are increasingly using enzyme-based diagnostic tests to develop effective treatment plans, particularly for patients with oncology and cardiac conditions. The troponin enzyme test, for instance, is one of the most popular cardiac enzyme tests. Hospitals prefer to measure troponin after 4 to 6 hours. Hospitals may perform the test again in some cases after 12 hours.

Regional Insights

North America was the dominant market for healthcare specialty enzymes in 2019, accounting for 38.2% of the total revenue. Due to its high penetration of enzyme technology, the region contributed more than USD 900.0 millions to the market. The region's growing sales and distributors are expected to increase the demand for specialty enzymes for healthcare.

It is easy to find new enzymes through the U.S. thanks to the presence of important players. Creative Enzymes is a U.S.-based company that offers enzymes for medical research, chemical industry, or environment protection. The company also produces enzymes that are suitable for cell biology, chemical processing, antibody research, and other applications. Due to the large market share for diagnostic consumables, and reagents, the Asia Pacific market for specialty enzymes in healthcare will grow at a rapid pace.

Market Share Insights & Key Companies

The market for healthcare specialty enzymes has seen a significant number of consolidations over the years. For the evaluation of clinical SARS CoV-2 samples, novel protocols have been created to allow direct RTqPCR without RNA extract. One protocol involves pretreatment of clinical samples using proteinase K. This removes the need to follow the standard procedure for purification and extracting a sample. This method is also efficient as 91.0% are in line with the COVID-19 standard RT-qPCR method. The market leader in healthcare specialty enzymes is:

• Advanced Enzymes Technologies Ltd

• Amano Enzymes, Inc.

• Amicogen

• BBI Solutions

• biotechrabbit GmbH

• Brain AG

• CPC Biotech

• Creative Enzymes

• EKF Diagnostics

• F. Hoffmann-La Roche Ltd

• Merck KGaA

• Sekisui Chemical Co. Ltd.

• Thermo Fisher Scientific, Inc.

Up Market Research published a new report titled “Healthcare Specialty Enzymes Market research report which is segmented by Source (Carbohydrases, Proteases), By Players/Companies Amicogen, Creative Enzymes, EKF Diagnostics, Brain AG, Merck KGaA, Sekisui Chemical Co Ltd, biotechrabbit GmbH, BBI Solutions, Advanced Enzymes Technologies Ltd, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, CPC Biotech, Amano Enzymes Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Healthcare Specialty Enzymes Market Report Segments:

The market is segmented by Source (Carbohydrases, Proteases).

Healthcare Specialty Enzymes Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Healthcare Specialty Enzymes Market

Overview of the regional outlook of the Healthcare Specialty Enzymes Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Healthcare Specialty Enzymes Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Healthcare Specialty Enzymes Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Carbohydrases

                2. Proteases

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Healthcare Specialty Enzymes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Healthcare Specialty Enzymes Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.